Apollo Hospitals shares climbed 2.06% on Friday after the company reported a 34% jump in profit for Q1 FY27. Investors are also evaluating the hospital chain's plan to add 5,800 beds and the divestment of its specialty and fertility units.
Shares of Apollo Hospitals Enterprises saw positive movement on Friday, trading up 2.06% to Rs 8,777.50. This market activity followed the company's strong financial performance for the first quarter of fiscal year 2027, which was disclosed earlier this week.
Strong Financial Performance
For the quarter ending June 2026, the company posted a consolidated revenue of Rs 7,043 crore, marking a 21% increase compared to the same period last year. Net profit saw a sharper rise, growing 34% year-on-year to Rs 581 crore. This growth was widespread across the company's primary business areas. The Healthcare Services segment recorded a 22% increase in revenue, while the Digital Health and Pharmacy division (HealthCo) saw a 20% rise. Additionally, the Diagnostics and Retail Health business grew by 15%.
Strategic Expansion and Divestment
Beyond quarterly earnings, the market is responding to significant strategic shifts announced by the company. Apollo Hospitals revealed plans to divest its Apollo Specialty Hospitals and Fertility Centre subsidiaries for Rs 1,550 crore. This move is part of a broader capital allocation strategy aimed at sharpening the focus on core operations. Simultaneously, the company has announced an ambitious infrastructure plan, with a target to add approximately 5,800 beds over the next five years. This expansion is intended to cater to growing demand in the healthcare sector, though it will require significant capital spending.
What Investors Should Monitor
While the company has shown consistent financial growth, investors are tracking several operational and strategic factors. A key monitorable is the planned listing of the Apollo HealthCo subsidiary, which is expected by the fourth quarter of fiscal year 2027. The company's management is also working to optimize the performance of newly commissioned hospitals, which can face temporary operational losses as they ramp up utilization.
Risks that investors typically watch in the healthcare sector include rising input and freight costs, which can put pressure on profit margins if not managed effectively. Additionally, the company's reliance on international patient inflows makes it sensitive to geopolitical factors and travel trends. On the corporate action front, today, August 14, 2026, marks the record date for the final dividend of Rs 10 per share for the fiscal year 2026, which may also be contributing to trading volume in the stock.
Looking ahead, the success of the 5,800-bed expansion and the timely execution of the HealthCo restructuring will be critical. Investors will likely look for management updates on project timelines and the impact of these initiatives on the company's long-term cash flow and return ratios.